GSK to fulfil Africa emerging market predictions, invests £130m
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline is to invest up to £130m ($216m) in Africa in order to secure long-term business in the region and tackle the growing burden of western diseases on the continent.